|
Wednesday 12th October 2022 |
Text too small? |
Rua Bioscience (NZX: RUA ) advises that all resolutions put to its hybrid Annual Shareholders’ Meeting (held online and in Gisborne today) were passed by Shareholders.
Those resolutions being:
- That the Board be authorised to fix the auditor’s remuneration.
- That Trevor Burt be re-elected as a director of Rua.
- That Brett Gamble be re-elected as a director of Rua.
- That Teresa Ciprian be re-elected as a director of Rua.
The results of the voting poll are in the attached document.
Ends
For more information, please visit www.ruabio.com or contact:
Media
Kerry Donovan
Communications Manager
+64 (21) 128 7689
kerry.donovan@ruabio.com
Investors
Hamish White
Chief Financial Officer
+64 (21) 050 5795
Hamish.white@ruabio.com
Rua Bioscience Results of the 2022 Annual Shareholders' Meeting
No comments yet
Devon Funds Morning Note - 02 December 2025
December 2nd Morning Report
SkyCity Announces Official Opening Date for NZICC
December 1st Morning Report
RAK - 1H26: Strong first half growth and strategic momentum
Green Cross Health Interim Results to 30 September 2025
Devon Funds Morning Note - 28 November 2025
November 28th Morning Report
Pacific Edge Appoints Chief Commercial Officer
Ryman Healthcare reports 1H26 results